Compositions and methods for quadricyclane modification of biomolecules
The present disclosure features a strain-promoted [2+2+2] reaction that can be carried out under physiological conditions. In general, the reaction involves reacting a pi-electrophile with a low lying LUMO with a quadricyclane on a biomolecule, generating a covalently modified biomolecule. The selectivity of the reaction and its compatibility with aqueous environments provides for its application in vivo and in vitro. The reaction is compatible with modification of living cells. In certain embodiments, the pi-electrophile can comprise a molecule of interest that is desired for delivery to a quadricyclane-containing biomolecule via [2+2+2] reaction.
1. A metal bis(dithiolene) compound of the formula (Ia) or (Ic):
wherein
M is selected from one of the following: nickel (II), palladium (II), platinum (II), cobalt (I), iridium (I), rhodium (I), copper (II), copper (III), silver (III), gold (III), tungsten, and iron;
Ar 1 , Ar 2 , Ar 3 , and Ar 4 are independently selected from aryl, substituted aryl, heteroaryl, and substituted heteroaryl groups;
R 1 , R 2 , R 3 , and R 4 are optional and are independently selected from alkylene, substituted alkylene, alkenylene, substituted alkenylene, alkynylene, substituted alkynylene, alkoxy, substituted alkoxy, aryl, substituted aryl, acyl, acylamino, aminoacyl, aminocarbonylamino, acyloxy, aminosulfonyl, sulfonylamino, amino, substituted amino, carboxyl ester, sulfonyl, sulfonyloxy, and thioalkoxy;
R 2 and R 3 are independently selected from the following: hydrogen, alkyl, substituted alkyl, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, alkoxy, substituted alkoxy, aryl, substituted aryl, acyl, acylamino, aminoacyl, aminocarbonylamino, acyloxy, aminosulfonyl, sulfonylamino, amino, substituted amino, carboxyl ester, sulfonyl, sulfonyloxy, and thioalkoxy: and
Y 1 , Y 2 , Y 3 , and Y 4 are independently selected from hydrogen; halogen; a moiety that comprises a reactive group that facilitates covalent attachment of a molecule of interest and is selected from the group consisting of amine, ester, thioester, sulfonyl halide, alcohol, thiol, succinimyl ester, isothiocyanate, iodoacetamide, maleimide, hydrazine, aminooxy, aldehyde, ketone, nitrile oxide, nitrone, tetrazine, azirine, tetrazole, alkene, alkyne, cyclooctyne, trans-cyclooctene, norbornene, and azide; and a molecule of interest;
wherein at least one of Y 1 , Y 2 , Y 3 , and Y 4 is the molecule of interest;
wherein the molecule of interest is selected from a peptide, an antigen-binding fragment of an antibody, an antibody and an epitope tag.
2. The metal bis(dithiolene) compound of claim 1 , wherein the compound is of the formula:
3. A metal bis(dithiolene) compound of the formula (la) or (lc):
wherein
M is selected from one of the following: gold (III), tungsten, and iron;
R 2′ and R 3′ are independently selected from the following: hydrogen, alkyl, substituted alkyl, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, alkoxy, substituted alkoxy, aryl, substituted aryl, acyl, acylamino, aminoacyl, aminocarbonylamino, acyloxy, aminosulfonyl, sulfonylamino, amino, substituted amino, carboxyl ester, sulfonyl, sulfonyloxy, and thioalkoxy;
R 1 , R 2 , R 3 and R 4 are optional and are independently selected from alkylene, substituted alkylene, alkenylene, substituted alkenylene, alkynylene, substituted alkynylene, alkoxy, substituted alkoxy, aryl, substituted aryl, acyl, acylamino, aminoacyl, aminocarbonylamino, acyloxy, aminosulfonyl, sulfonylamino, amino, substituted amino, carboxyl ester, sulfonyl, sulfonyloxy, and thioalkoxy; and
Y 1 , Y 2 , Y 3 and Y 4 are independently selected from hydrogen; halogen; a moiety that comprises a reactive group that facilitates covalent attachment of a molecule of interest and is selected from the group consisting of amine, ester, thioester, sulfonyl halide, alcohol, thiol, succinimyl ester, isothiocyanate, iodoacetamide, maleimide, hydrazine, aminooxy, aldehyde, ketone, nitrile oxide, nitrone, tetrazine, azirine, tetrazole, alkene, alkyne, cyclooctyne, trans-cyclooctene, norbornene, and azide; and a molecule of interest;
wherein at least one of Y 1 and Y 4 is the molecule of interest;
wherein the molecule of interest is selected from the group consisting of a radioactive label, a positron emission tomography (PET) imaging label, a peptide, a drug, biotin, an antigen-binding fragment of an antibody, an antibody and an epitope tag.
4. The compound of any one of claims 1 and 2, wherein M is selected from gold (III), tungsten, and iron.
5. The compound of any one of claims 1 and 2, wherein M is selected from nickel (II), palladium (II), and platinum (II).
6. The compound of claim 1 , wherein Ar 1 , Ar 2 , Ar 3 , and Ar 4 are each independently heteroaryl, or substituted heteroaryl groups.
7. The compound of claim 1 wherein Ar 1 , Ar 2 , Ar 3 , and Ar 4 are each independently aryl or substituted aryl.
8. The compound of claim 3 wherein the compound is of the formula (Ic) and R 2′ and R 3 ′ are each substituted aryl.
9. The compound of any one of claims 1-3, wherein the compound is of the formula (Ia) and le, R 1 , R 2 , R 3 , or R 4 is alkylene, substituted alkylene, alkenylene, substituted alkenylene, alkynylene, or substituted alkynylene.
10. The compound of claim 2 wherein R 2 and R 3 are independently selected from aryl, substituted aryl, alkyl or substituted alkyl.
11. The compound of claim 1 wherein the compound is of the formula:
12. A compound of the formula:
wherein Y 2 and Y 3 are independently selected from hydrogen; halogen; and a moiety that comprises a reactive group that facilitates covalent attachment of a molecule of interest and is selected from amine, ester, thioester, sulfonyl halide, alcohol, thiol, succinimyl ester, isothiocyanate, iodoacetamide, maleimide, hydrazine, aminooxy, aldehyde, ketone, nitrile oxide, nitrone, tetrazine, azirine, tetrazole, alkene, alkyne, cyclooctyne, trans-cyclooctene, norbornene and azide.
13. The compound of claim 3 , wherein the molecule of interest is selected from a peptide, a drug, an antigen-binding fragment of an antibody, an antibody and an epitope tag.
14. The compound of claim 13 , wherein the molecule of interest is selected from a peptide, an epitope tag, an antigen-binding fragment of an antibody and an antibody.
15. The compound of claim 13 , wherein the molecule of interest is a drug.